Category: by publisher

And the award for the most self-referential abstract ever goes to…

dev cogn neuroscienceHere at Retraction Watch, we like to dig for what lies behind sometimes opaque retraction notices. But today, thanks to Neil Martin, we have a glimpse into something a bit different: The back-and-forth between an author and his editor.

In Developmental Cognitive Neuroscience, Peter Reiner, of the University of British Columbia, wrote a comment on “Can transcranial electrical stimulation improve learning difficulties in atypical brain development? A future possibility for cognitive training,” by Beatrix Krause and Roi Cohen Kadosh.(Recent related work by Cohen Kadosh’s group has earned some media attention.

The comment is pretty straightforward, except for what’s listed as the abstract: Continue reading And the award for the most self-referential abstract ever goes to…

A double-bill from Digestive Diseases and Sciences, both for regurgitation — aka duplication

ddsComing back up?

Digestive Diseases and Sciences has retracted two papers for duplication.

The first paper, “Membrane-Bound Mucins and Mucin Terminal Glycans Expression in Idiopathic or Helicobacter pylori, NSAID Associated Peptic Ulcers,” was published in October 2012 by a group from Israel and the United States. It found that:

Cytoplasmic MUC17 staining was significantly decreased in the cases with idiopathic ulcer. The opposite was demonstrated for MUC1. This observation might be important, since different mucins with altered sialylation patterns likely differ in their protection efficiency against acid and pepsin.

But, as the retraction notice suggests, that much had been found before: Continue reading A double-bill from Digestive Diseases and Sciences, both for regurgitation — aka duplication

Five Kato papers subject to an expression of concern, plus, a statute of limitations on correcting the literature?

katoShigeaki Kato, an endocrinology researcher who resigned last year from the University of Tokyo and has retracted five papers, now has five more papers subject to an expression of concern.

Here’s the notice in Molecular and Cellular Biology: Continue reading Five Kato papers subject to an expression of concern, plus, a statute of limitations on correcting the literature?

Retraction cites “unintended excessive reuse” in commentary — of paper it was praising

rejuvreschcoverWe here at Retraction Watch HQ are always on the lookout for euphemisms for plagiarism (and other misconduct, of course). Among our favorites are “referencing failure” and the journal that allowed researchers to call plagiarism an “approach” to writing.

Here’s a new one that’s sure to do well with voters.

The journal Rejuvenation Research has retracted a commentary for, well, containing too much of the very text it was supposed to be commenting on.

The editorial was by Giorgio Aicardi, of the University of Bologna, in Italy, and the article Aicardi was writing about was titled “Synaptic distributions of GluA2 and PKMζ in the monkey dentate gyrus and their relationships with aging and memory.” That article had been published in the Journal of Neuroscience last year by a group from Mount Sinai in New York.

We’ll let the notice do the explaining: Continue reading Retraction cites “unintended excessive reuse” in commentary — of paper it was praising

Authors hit for image manipulation cycle, but don’t worry, they’ll resubmit retracted paper

j virologyRegrets were had, mistakes were made, but gosh-darn-it, they’re gonna resubmit that retracted paper in the future.

Such is the message from a retraction of “Tsg101 Interacts with Herpes Simplex Virus 1 VP1/2 and Is a Substrate of VP1/2 Ubiquitin-Specific Protease Domain Activity,” from Italian virologists who admitted to copying and pasting their way into the Journal of Virology: Continue reading Authors hit for image manipulation cycle, but don’t worry, they’ll resubmit retracted paper

Updated: Integrity “uncertain,” journal retracts stroke paper

emmcover

Experimental & Molecular Medicine has retracted a 2012 paper on stroke by a group of South Korean researchers after learning that one of the figures in the article was unreliable.

The article was titled “Protective effects of transduced Tat-DJ-1 protein against oxidative stress and ischemic brain injury,” and it came from a team at Hallym University in Chunchon.

According to the retraction notice: Continue reading Updated: Integrity “uncertain,” journal retracts stroke paper

Duplicate submission costs authors two papers on Parkinson’s disease

neuropeptidecoverA group of pharmacology researchers in the UK has lost two papers after submitting effectively identical versions to different journals — and getting them accepted, of course — just a day apart.

The first article appeared on the British Journal of Pharmacology‘s website on July 10, 2012. It was titled “Exendin-4 reverts behavioural and neurochemicaldysfunction in a pre-motor rodent model of Parkinson’s disease with noradrenergic deficit.”

Paper 2 appeared in the journal Neuropeptides in October, although it has an online pub date of August 24, and was titled “Exendin-4 reverses biochemical and behavioral deficits in a pre-motor rodent model of Parkinson’s disease with combined noradrenergic and serotonergic lesions.”

Continue reading Duplicate submission costs authors two papers on Parkinson’s disease

Cardiology journals retract five Matsubara studies

matsubaraThe American Heart Association (AHA) is retracting five studies by Hiroaki Matsubara, a former Kyoto Prefectural University cardiology researcher, that it had subjected to an expression of concern last year.

Here’s the notice: Continue reading Cardiology journals retract five Matsubara studies

Ulrich Lichtenthaler now up to 12 retractions

industrial corp changeIndustrial and Corporate Change is the site of management professor Ulrich Lichtenthaler’s 12th retraction.

Here’s the notice for “Outward knowledge transfer: the impact of project-based organization on performance,” originally published in 2010: Continue reading Ulrich Lichtenthaler now up to 12 retractions

Author break prompts retraction of bone protein paper

ejpcoverThe European Journal of Pharmacology has — against its will, it would seem — retracted a 2012 paper by a group of Chinese heart researchers embroiled in a what appears to be a rather messy authorship dispute.

The article, “The effect of alendronate on the expression of osteopontin and osteoprotegerin in calcified aortic tissue of the rat,”  came from the Institute of Cardiovascular Disease at Tongji Hospital, part of of Huazhong University of Science and Technology.

As the retraction notice states:

Continue reading Author break prompts retraction of bone protein paper